Under an exclusive marketing agreement, Neurobiological Technologies (NTI) currently receives quarterly royalty payments on certain sales of Memantine by Merz and its marketing partners.
The placebo-controlled, randomized trial is a parallel-group dose-response study of the ability of ITX5061 to reduce viral load in treatment-naive and previously treated patients with hepatitis C virus
The collaboration will include studies of cancer-related microRNAs that were discovered at both Mirna and University of California, San Francisco (UCSF) as well as small RNAs that will
Tepnel’s board of directors intends to recommend that its shareholders approve the transaction, which is expected to close in the second quarter of 2009. Already, directors and institutional
CyDex has an international patent cooperation treaty application pending for this combination nasal spray product. A randomized, double-blind, placebo-controlled, three-way cross-over study was conducted in 108 seasonal allergic
Mr Rainey began his career as staff account manager at Ernst & Young in Philadelphia. From 1997-2008 at Avax, Mr Rainey held several leadership positions including CEO, president,
The suit was brought in the US District Court of Delaware. Two patents at issue in this suit, related to Masimo’s measure-through-motion technology, were successfully enforced in a
GlaxoSmithKline, or GSK, and Genmab have submitted a biologics license application to the FDA for Arzerra to treat patients whose chronic lymphocytic leukemia is resistant to previous therapies.
The committee reviewed comprehensive data primarily from the Triton TIMI-38 clinical trial. Results from the Triton trial showed that prasugrel taken with aspirin reduced the relative risk of
The Urief tablet is a new formulation of Urief capsule 2mg and Urief capsule 4mg, which were jointly marketed by Daiichi Sankyo and Kissei in Japan since 2006.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.